Nov 18, 2021

Israeli oral COVID vaccine heads to Mexico, aims to fast-track approval

Posted by in category: biotech/medical

Oramed Pharmaceuticals, the developer of the Oravax oral COVID-19 vaccine candidate, has announced a partnership with Mexico’s Genomma Lab Internacional to help fast-track a Phase II clinical trial and gain emergency use authorization in the Latin American country.

Only about 58% of Mexico’s population has been jabbed with one dose of a coronavirus vaccine, averaging around 4,500 new cases per day.

Leave a reply